ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013